This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Volker Schnecke: Innovator in Therapeutic Agents
Introduction
Volker Schnecke is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of therapeutic agents, particularly in the treatment and prevention of diseases mediated through glucokinase.
Latest Patents
Schnecke holds a patent for a compound of Formula (I), which is useful in the treatment or prevention of a medical condition that involves glucokinase. This innovation leads to a decreased glucose threshold for insulin secretion, showcasing his commitment to advancing medical science.
Career Highlights
Volker Schnecke is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on developing innovative solutions that address critical health challenges.
Collaborations
He has collaborated with esteemed colleagues, including Stuart Norman Lile Bennett and Roger John Butlin, to further enhance the impact of his research and innovations.
Conclusion
Volker Schnecke's contributions to therapeutic agents exemplify the vital role of inventors in advancing healthcare solutions. His work continues to influence the medical field positively.